Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Study of the Efficacy and Safety of Divozilimab in Patients With Neuromyelitis Optica Spectrum Disorders

NCT05730699 is registered in ClinicalTrials.gov with Biocad as lead sponsor.

NCT NCT05730699
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05730699 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Study of the Efficacy and Safety of Divozilimab in Patients With Neuromyelitis Optica Spectrum Disorders
Lead sponsor
Biocad
Phase
Phase 3
Overall status
Active, not recruiting
Start date
December 12, 2022
Completion date
September 30, 2026
Enrollment
105 (estimated)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

neuromyelitis optica spectrum disorders